This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Alzheimer's Disease & Dementia Conference" (Dementia 2025) June 05-07, 2025 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at dementia@magnusconference.com or call + 1 (702) 988 2320.
Dementia is characterized by a wide range of psychological symptoms and behavioral problems. Dementia patients with such behavioral abnormalities account for 30 percent to 90 percent of all dementia patients. Depression, apathy, violence, and psychosis are widely recognized as essential hallmarks of Alzheimer's disease (AD), and there is a general understanding that symptom intensity is associated with faster cognitive decline, loss of independence, and even shorter survival. It's unknown if these symptoms are caused by the same pathogenic processes that cause cognitive decline or have separate etiologies unrelated to AD-related neurodegeneration. Regardless of whether these symptoms are linked to AD etiology and cognitive decline, their negative impact on patient and caregiver quality of life calls for more research into more effective therapies.
Important Alert:
X
Title : Early clinical development of modified P8 for the treatment of alzheimer’s disease
Nazneen N Dewji, Cenna Biosciences Inc, United States
Title : Who cares for the carers
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Memory should be the primary endpoint in early AD
Matthias W Riepe, Ulm University, Germany
Title : Down’s syndrome (trisomy 21) and alzheimer disease: A common medical and scientific fight
London Jacqueline, Paris Diderot University, France
Title : Quality of life children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Efficacy of transcranial photobiomodulation in mild cognitive impairment and early alzheimer’s Disease: A randomized controlled study
Hyelim Chun, St.Peter’s General Hospital, Korea, Republic of